JAN 27, 2022 3:00 AM PST

Can Magnesium Help the Immune System Fight Cancer?

WRITTEN BY: Katie Kokolus

Magnesium deficiency is associated with some types of cancer, including breast, ovarian, and kidney cancer.  Pre-clinical studies have demonstrated that, while inhibiting primary tumor growth, a low magnesium diet promoted tumor metastasis.  The current literature on cancer and magnesium is incomplete and lacks large-scale controlled clinical trials.  Additionally, any immunological mechanism describing how magnesium, or lack thereof, influences cancer growth and development remains unclear.

A recent study published in Cell has investigated the role of magnesium in the anti-tumor immune response. The authors found that a molecule called Lymphocyte function-associated antigen 1 (LFA-1) was a key regulator in the cancer development associated with magnesium deficiency. LFA-1 is an immune-stimulating marker found on the surface of different types of immune cells. Critical immune functions, including the migration and activation of CD8+ T cells, immune cells responsible for cancer cell killing, are dependent on LFA-1.  

Like many proteins, LFA-1 regulation is dictated by conformational changes.  Importantly, each conformational state of LFA-1 directly impacts the immune response.  When closed/bent, LFA-1 prevents T cells immunity against cancer cells.  However, when open/extended, LFA-1 can facilitate anti-tumor immunity.

The study describes the impact of magnesium on conformational changes in LFA-1.  Specifically, the authors show that magnesium is required to adopt the open/extended conformational state.  Importantly, this work demonstrates that magnesium promotes cytotoxicity, the process by which CD8+ T cells kill cancer cells.

The authors also investigated the impact of magnesium on response to two different types of immunotherapy, a chimeric antigen receptor-T (CAR T) cells and an immune checkpoint inhibitor (ICI). The authors performed a retrospective analysis on a cohort of B cell lymphoma patients treated with CD19-directed CAR T cells. Additionally, the researchers analyzed outcomes in a cohort of non-small cell lung cancer patients treated with an ICI combined with chemotherapy. Patients who experienced magnesium deficits were less responsive to therapy and had reduced survival compared to patients with normal magnesium levels.   

The researchers conclude that magnesium significantly impacts the immune response by regulating T cell activities through influencing conformation changes in LFA-1.  Because the data presented in this study is retrospective, the authors acknowledge that prospective clinical trials are needed to determine the clinical relevance of magnesium in cancer treatment regimens. 

 

Sources: Scientific Reports, Oncologist, Kidney360, Biochim Biophys Acta, Cell, Front Immunol

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
JAN 10, 2022
Cancer
Race May Impact Radiation Efficacy in Prostate Cancer Patients
JAN 10, 2022
Race May Impact Radiation Efficacy in Prostate Cancer Patients
Racial disparities exist between Black and White populations in many types of cancer.  Researchers actively investi ...
FEB 22, 2022
Cancer
What's Killing My Cell Cultures? Troubleshooting Cell Growth Issues
FEB 22, 2022
What's Killing My Cell Cultures? Troubleshooting Cell Growth Issues
Nothing's more maddening than cells that won't grow or cell cultures that won't attach. Stunted cell growth and erratic ...
MAR 08, 2022
Technology
Black Prostate Cancer Patients Are Less Likely to Receive Diagnostic MRIs. Why?
MAR 08, 2022
Black Prostate Cancer Patients Are Less Likely to Receive Diagnostic MRIs. Why?
Prostate cancer affects an estimated 1 in 8 men, with over 250,000 new cases diagnosed each year. More specifically, pro ...
APR 19, 2022
Health & Medicine
Microplastics Found in Human Lungs. Are They Dangerous?
APR 19, 2022
Microplastics Found in Human Lungs. Are They Dangerous?
Research out of Hull York Medical School in England found small plastic debris known as microplastics deep in the lungs ...
APR 28, 2022
Drug Discovery & Development
Keto Molecule Shows Promise for Treating Colorectal Cancer
APR 28, 2022
Keto Molecule Shows Promise for Treating Colorectal Cancer
A molecule produced when on low-carbohydrate ketogenic diets suppresses the growth of colorectal tumors in the lab. The ...
MAY 01, 2022
Health & Medicine
Predicting Radiotherapy Resistance in Brain Metastases
MAY 01, 2022
Predicting Radiotherapy Resistance in Brain Metastases
Radiotherapy for brain metastasis can later cause neurocognitive decline. Sometimes this is a tradeoff when fightin ...
Loading Comments...